Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(13 sites)
United States
University of California San Francisco, San Francisco, California Sylvester Comprehensive Cancer Center, Miami, Florida Hematology Oncology Associates of the Treasure Coast, Port Saint Lucie, Florida Mayo Clinic, Rochester, Minnesota START New York Long Island, LLC, New Hyde Park, New York NYU Langone Health, New York, New York Columbia University Irving Medical Center, New York, New York Memorial Sloan Kettering Cancer Center, New York, New York Duke Cancer Center, Durham, North Carolina The Ohio State University Comprehensive Cancer Center, Columbus, Ohio Carolina Urologic Research Center, the START Center for Cancer Research, Myrtle Beach, South Carolina USA Clinical Trials, San Antonio, Texas University of Wisconsin, Madison, Wisconsin